on until the 2nd quarter of 2018 unless there is the progress of the said rehabilitation plan. 2. Business Outlook on Q1/2018 Management’s Discussion and Analysis (MD&A) for year 2017 3 Executive

of November 2017 and expect to go on until the 2nd quarter of 2018 unless there is the progress of the said rehabilitation plan. 2. Business Outlook on Q1/2018 Management’s Discussion and Analysis (MD

ordinary shares of 1,437,456,000 shares under IPO with a par value of THB 5.00 per share and IPO price at THB 5.20 per share. This capital raising will reduce interest bearing debt to equity ratio of both

) (149.44) 41.71 27.91% 6 Finance costs (14.56) (13.10) 1.46 11.15% Share of profit (loss) of associates (1.32) - 1.32 100.00% 7 Profit before income tax 104.50 78.33 26.17 33.41% Income tax (30.75) (19.28

-5.04 -25.4% Administrative expenses 25.75 25.02 0.73 2.9% Total expenses 741.40 690.89 50.51 7.3% Earning before interest and tax 75.54 61.16 14.38 23.5% Financial expenses -1.64 -2.72 1.08 -39.7% Share

were back on track with 44.5% growth YoY and 3.4% growth QoQ. - In Q1’19, the Company maintained its leadership position with total market share of 31.1% in Brain and Body Boost (“BBB”) products which

expenses 115.49 106.14 9.35 8.8% Total expenses 3,065.73 3,066.16 -0.43 0.0% Earning before interest and tax 253.50 341.41 -87.91 -25.8% Finance cost -5.55 -4.83 -0.72 14.9% Share of profit from investment

104.79 1.35 1.3% Total expenses 3,066.16 2,946.38 119.78 4.1% Earning before interest and tax 341.41 279.67 61.74 22.1% Finance cost -4.83 -8.02 3.19 -39.8% Share of profit from investment in associate

= Translation = Management Discussion and Analysis for Interim Business Operations The Information of Share Capital Registration and Entire Business Transfer The Company registered the change of

1.27 8.6% Administrative expenses 28.79 25.75 3.04 11.8% Total expenses 788.14 741.40 46.74 6.3% Earning before interest and tax 71.92 75.54 -3.62 -4.8% Financial expenses -1.33 -1.64 0.31 -18.9% Share